|
925 Chestnut Street (215) 955-5161 |
|
Medical School
Residency
Fellowship
Board Certification
Hospital Appointment
University Appointment Research and Clinical Interests At Jefferson, he serves as the Director of the Pulmonary Vascular Disease Program and one full day weekly, evaluates patients for pulmonary hypertension at the Jefferson Heart Institute. His patients receive PAH-specific medicines under his direction, including parenteral and inhaled prostacyclins and oral therapies. His research interests include exercise assessment in PAH, evaluation of sleep disorders in PAH, and right heart dysfunction in sickle cell patients. He is the principal investigator in industry-sponsored various PAH-related trials and registries. Dr. Scharf also evaluates and treats patients with general pulmonary issues and serves as the medical director of the Jefferson University Physicians' pulmonary outpatient practice. |
||
|
Publications Most recent Peer-reviewed Publications |